TURTLE CAMERON (Chief Executive Officer) sold 2.1% of their position (15K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $435.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/3/2025ACC: 0001758363-25-000003
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-15K
Net shares
Net seller
$435.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
15K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−10.99K
Price / share
$28.73
Trade value
$315.89K
% of position
1.6%
12/1/2025
701.91K→690.91K
Common Stock
Direct
Shares
−4K
Price / share
$29.83
Trade value
$119.47K
% of position
0.6%
12/1/2025
690.91K→686.91K
Total
Net shares
−15K
Net value
-$435.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2025 | S · Sale | −10.99K | $28.73 | $315.89K | 1.6% | 701.91K | 690.91K |
| Common Stock Direct | 12/1/2025 | S · Sale | −4K | $29.83 | $119.47K | 0.6% | 690.91K | 686.91K |
| Total | −15K | -$435.36K | ||||||
Derivative Transactions0
No derivative transactions reported